Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gemtuzumab ozogamicin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing gemtuzumab ozogamicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gemtuzumab ozogamicin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing gemtuzumab ozogamicin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gemtuzumab ozogamicin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only gemtuzumab ozogamicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gemtuzumab ozogamicin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Gemtuzumab ozogamicin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gemtuzumab ozogamicin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Gemtuzumab ozogamicin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Gemtuzumab ozogamicin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Gemtuzumab ozogamicin 5 mg powder for solution for infusion vial |
Has precise active ingredient |
True |
Gemtuzumab ozogamicin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Gemtuzumab ozogamicin 5 mg powder for solution for infusion vial |
Has basis of strength substance (attribute) |
True |
Gemtuzumab ozogamicin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Gemtuzumab ozogamicin 5 mg powder for solution for infusion and/or injection vial |
Has precise active ingredient |
True |
Gemtuzumab ozogamicin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Gemtuzumab ozogamicin 5 mg powder for solution for infusion and/or injection vial |
Has basis of strength substance (attribute) |
True |
Gemtuzumab ozogamicin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |